Redhill Biopharma H1 2026 EPS $0.00 And Revenue $0.00

Benzinga Newsdesk www.benzinga.com Neutral 80.4%

Neg 0% Neu 80.4% Pos 0%

Redhill Biopharma (NASDAQ:RDHL) reported H1 2026 EPS $0.00 And Revenue $0.00.

Comments

No comments yet. Be the first!